{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:36:25Z","timestamp":1793028985392,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Nottingham Biomedical Research Centre","award":["IS-BRC-1215-20003"],"award-info":[{"award-number":["IS-BRC-1215-20003"]}],"id":[{"id":"https:\/\/ror.org\/046cr9566","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Biliary tract cancer (BTC) has a poor prognosis with limited therapeutic options. \u03b3\u03b4 T cells represent an MHC-independent immune cell population; however, their therapeutic efficacy in solid tumors is constrained by insufficient tumor infiltration. Chemokine-mediated trafficking is fundamental to T lymphocyte recruitment; however, the chemokine landscape of the BTC tumor microenvironment (TME) remains uncharacterized. Using single-cell RNA sequencing of BTC tissues, we delineated chemokine ligand expression patterns, stratified chemokine producers by lineage, assessed \u03b3\u03b4 T-cell recruitment mechanisms, and identified chemokine-mediated immune escape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed single-cell RNA sequencing data from 3 independent GEO cohorts (GSE210066, GSE201425, and GSE213452; 19 patients) to comprehensively delineate \u03b3\u03b4 T-cell mobilization-related chemokine expression across the BTC TME using the Seurat v5.0 pipeline in R.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Analysis identified a multiaxis chemokine profile within the BTC TME. High expression of CCL5, CCL4, and CCL3 established predominant CCR5-mediated recruitment axes supporting V\u03b39V\u03b42 T-cell infiltration, whereas CCL2 and modest CXCL8 supported CCR2\n                      <jats:sup>+<\/jats:sup>\n                      and CXCR1\n                      <jats:sup>+<\/jats:sup>\n                      V\u03b41 T-cell recruitment. Notably, CXCL16 expression supported epithelial \u03b3\u03b4 T-cell homing through CXCR6. However, critical deficiencies in CXCL9 and CXCL10 suppress the IFN-\u03b3-driven immunity. Paradoxically, chemokine axes supporting \u03b3\u03b4 T-cell recruitment (CCL2-CCR2, CXCL8-CXCR1, CXCL12-CXCR4) simultaneously recruit immunosuppressive populations, such as myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and tumor-associated macrophages (TAMs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Comprehensive single-cell analysis identified selective chemokine recruitment signatures supporting \u03b3\u03b4 T-cell infiltration but revealed paradoxical corecruitment of immunosuppressive populations. Patient stratification through chemokine profiling, combined with \u03b3\u03b4 T-cell enrichment and targeted chemokine antagonism, represents a rational therapeutic strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/coc.0000000000001306","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:00:37Z","timestamp":1771513237000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Relevance of Chemokines in Mobilizing \u03b3\u03b4 T Cells in the Biliary Tract Cancer Microenvironment: Potential for \u03b3\u03b4 T-Cell\u2013Based Adoptive Cell Therapy"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Saikat","family":"Mandal","sequence":"first","affiliation":[{"name":"School of Medicine, University of Nottingham"},{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-2569","authenticated-orcid":false,"given":"Arkadeep","family":"Dhali","sequence":"additional","affiliation":[{"name":"Faculty of Health, Imperial College, London"},{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-5158","authenticated-orcid":false,"given":"Manideepa","family":"Maji","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of Hull"},{"name":"Haematology, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruprasad","family":"Aithal","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Nottingham"},{"name":"NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"R1-20261026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20261026","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17474124.2018.1489229","article-title":"Challenges of surgical management of intrahepatic cholangiocarcinoma","volume":"12","author":"Squires","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R3-20261026","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"American Joint Committee on Cancer Cancer Staging Manual","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R4-20261026","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","article-title":"Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches","volume":"155","author":"Tsilimigras","year":"2020","journal-title":"JAMA surgery"},{"key":"R5-20261026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"R6-20261026","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"R7-20261026","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.21873\/anticanres.15829","article-title":"Synergistic benefit of adoptive T cells in combination with chemoradiotherapy against metastatic prostate cancer cells","volume":"42","author":"Shen","year":"2022","journal-title":"Anticancer Res"},{"key":"R8-20261026","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/bjc.2015.337","article-title":"Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer","volume":"113","author":"Goeppert","year":"2015","journal-title":"Br J Cancer"},{"key":"R9-20261026","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","article-title":"PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma","volume":"22","author":"Sabbatino","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R10-20261026","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3389\/fimmu.2017.01714","article-title":"Mevalonate metabolism in immuno-oncology","volume":"8","author":"Gruenbacher","year":"2017","journal-title":"Front Immunol"},{"key":"R11-20261026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41423-024-01135-z","article-title":"Unsynchronized butyrophilin molecules dictate cancer cell evasion of V\u03b39V\u03b42 T-cell killing","volume":"21","author":"Wu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"R12-20261026","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"R13-20261026","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"R14-20261026","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"R15-20261026","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.4049\/jimmunol.168.10.4920","article-title":"Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2\/V gamma 9 gamma delta T cells","volume":"168","author":"Glatzel","year":"2002","journal-title":"J Immunol"},{"key":"R16-20261026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1615\/CritRevImmunol.v23.i56.10","article-title":"Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors","volume":"23","author":"Kabelitz","year":"2003","journal-title":"Crit Rev Immunol"},{"key":"R17-20261026","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.4049\/jimmunol.1300434","article-title":"Protective role of the inflammatory CCR2\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic \u03b3\u03b4 T lymphocytes to tumor beds","volume":"190","author":"Lan\u00e7a","year":"2013","journal-title":"J Immunol"},{"key":"R18-20261026","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R19-20261026","doi-asserted-by":"crossref","first-page":"111384","DOI":"10.1016\/j.celrep.2022.111384","article-title":"Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis","volume":"40","author":"Keenan","year":"2022","journal-title":"Cell Rep"},{"key":"R20-20261026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41698-022-00300-9","article-title":"Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment","volume":"6","author":"Shi","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"R22-20261026","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"R23-20261026","doi-asserted-by":"crossref","first-page":"e008355","DOI":"10.1136\/jitc-2023-008355","article-title":"Multiomics profiling reveals the benefits of gamma-delta (\u03b3\u03b4) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer","volume":"12","author":"Li","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"D1","key":"R24-20261026","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R25-20261026","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumor and tumor-associated macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin Exp Med"},{"key":"R26-20261026","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.3390\/ijms26157624","article-title":"Transcriptional repression of CCL2 by KCa3.1 K+ channel activation and LRRC8A anion channel inhibition in THP-1-differentiated M2 macrophages","volume":"26","author":"Matsui","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R27-20261026","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hep.31412","article-title":"Intratumoral \u03b3\u03b4 T-cell infiltrates, chemokine (C-C motif) ligand 4\/chemokine (C-C motif) ligand 5 protein expression and survival in patients with hepatocellular carcinoma","volume":"73","author":"Zhao","year":"2021","journal-title":"Hepatology"},{"issue":"pt 2","key":"R28-20261026","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semcancer.2022.06.010","article-title":"Chemokines and NSCLC: emerging role in prognosis, heterogeneity, and therapeutics","volume":"86","author":"Srivastava","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R29-20261026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"R30-20261026","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R31-20261026","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"R32-20261026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2010-0265OC","article-title":"The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis","volume":"45","author":"Yang","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R33-20261026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R34-20261026","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"R35-20261026","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signalling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Sig Transduct Target Ther"},{"issue":"pt 2","key":"R36-20261026","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2022.06.002","article-title":"Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact","volume":"86","author":"Braoudaki","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R37-20261026","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-15-1938","article-title":"PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer","volume":"76","author":"Nagarsheth","year":"2016","journal-title":"Cancer Res"},{"key":"R38-20261026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nri.2017.101","article-title":"\u03b3\u03b4 T cells in homeostasis and host defence of epithelial barrier tissues","volume":"17","author":"Nielsen","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R39-20261026","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fimmu.2018.00985","article-title":"Human gammadelta T-cell control of mucosal immunity and inflammation","volume":"9","author":"McCarthy","year":"2018","journal-title":"Front Immunol"},{"key":"R40-20261026","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"key":"R41-20261026","doi-asserted-by":"crossref","first-page":"574667","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front Pharmacol"},{"key":"R42-20261026","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.3390\/ijms22073490","article-title":"The role of CXCL16 in the pathogenesis of cancer and other diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R43-20261026","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00262-007-0391-3","article-title":"Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas","volume":"57","author":"Bouet-Toussaint","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R44-20261026","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/1744666X.2017.1384313","article-title":"Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3","volume":"13","author":"Schaller","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"R45-20261026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1158\/0008-5472.CAN-09-2326","article-title":"CCL2 blockade augments cancer immunotherapy","volume":"70","author":"Fridlender","year":"2010","journal-title":"Cancer Res"},{"key":"R46-20261026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/molecules27010137","article-title":"Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy","volume":"27","author":"Han","year":"2021","journal-title":"Molecules"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:00:25Z","timestamp":1793026825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001306","relation":{},"ISSN":["0277-3732","1537-453X"],"issn-type":[{"value":"0277-3732","type":"print"},{"value":"1537-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"2025-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}